This issue of the SFARI newsletter includes: (1) Analysis of postmortem brain tissue from the Autism BrainNet collection – Request for applications, (2) 2021 Genomics of ASD: Pathways to Genetic Therapies awardees announced, (3) Autism BrainNet to digitize the Autism Celloidin Library of postmortem brains, (4) Neuroscience 2021: Presentations by SFARI Investigators, (5) SFARI Investigators awarded Nobel Prize, Lasker Award and MacArthur Fellowship, (6) Highlights of SFARI-funded research, (7) SFARI Supplement to Enhance Equity and Diversity (SEED) – Request for applications, (8) SPARK Research Match Diversity, Equity and Inclusivity – Request for applications.

This issue of the SFARI newsletter includes: (1) 2021 SFARI Human Cognitive and Behavioral Science awardees announced, (2) New zebrafish lines added to SFARI resources, (3) ASHG 2021 Virtual Meeting: Presentations by SFARI Investigators and collaborators, (5) A Conversation with SFARI consultant-in-residence Gaspar Taroncher-Oldenburg, (6) Highlights of SFARI-funded research, (7) SFARI Supplement to Enhance Equity and Diversity – Request for applications, (8) SPARK Research Match Diversity, Equity and Inclusivity – Request for applications.

This issue of the SFARI newsletter includes: (1) SFARI 2021 Bridge to Independence fellows announced, (2) SFARI announces the awardees of the Supplemental Funding for Studies of Maternal COVID-19 as a Potential Risk for Autism, (3) SPARK: Five years accelerating autism gene discovery and research, (4) SFARI workshop explores sleep challenges in autism spectrum disorder, (5) A Conversation with SFARI BTI and SEED awardee J. Elliott Robinson, (6) Highlights of SFARI-funded research, (7) Autism Rat Models Consortium – Request for applications, (8) SFARI Supplement to Enhance Equity and Diversity – Request for applications, (9) SPARK Research Match Diversity, Equity and Inclusivity – Request for applications.

This issue of the SFARI newsletter includes: (1) Kelsey Martin to lead the Simons Foundation Autism Research Initiative, Neuroscience Collaborations, (2) 2020 SFARI Collaboration on Sex Differences in Autism awardees annonunced, (3) SFARI Investigators and affiliated staff apointed to the Interagency Autism Coordinating Committee, (4) Autism BrainNet tissue requests can now be made through SFARI Base, (5) Highlights of SFARI-funded research, (6) Autism Rat Models Consortium – Request for applications, (7) SFARI Supplement to Enhance Equity and Diversity (SEED) – Request for applications, (8) SPARK Research Match Diversity, Equity and Inclusivity – Request for applications

This issue of the SFARI newsletter includes: (1) 2021 Genomics of ASD: Pathways to Genetic Therapies – Request for applications, (2) 10 years of Simons Searchlight: Advancing research on autism and genetic neurodevelopmental conditions, (3) 2021 Autism BrainNet Appreciation Award: Recipients announced, (4) SFARI continues support of Summer Undergraduate Research Program, (5) SFARI presentations at INSAR 2021 Virtual Annual Meeting, (6) SFARI workshop explores the use of rat models in autism research, (7) Highlights of SFARI-funded research, (8) SFARI Supplement to Enhance Equity and Diversity (SEED) — Request for applications, (9) SPARK Research Match Diversity, Equity and Inclusivity – Request for applications, (10) Past lecture: Jake Gratten and Naomi Wray, “New research results from the Australian Autism Biobank Study, (11) Past lecture: Federico Bolognani, Stuart Cobb, Yael Weiss, and Randal Carpenter, “Small molecules, genes and antisense oligonucleotides: Industry perspectives on treatment development for ASD, (12) Past lecture: David Ledbetter, Joseph Buxbaum, and Heather Mefford, “What do we mean by ‘autism risk genes?”

This issue of the SFARI newsletter includes: (1) Updates to SFARI’s 2021 requests for grant applications, (2) SFARI 2020 Director Awards announced, (3) A message from SFARI regarding anti-Asian violence, (4) Simons Searchlight: April 2021 data release, (5) SFARI meeting report: SFARI Fall 2020 science meeting highlights new developments in autism research, (6) A Conversation with SFARI Bridge to Independence Investigator Aakanksha Singhvi, (7) Highlights of SFARI-funded research, (8) 2021 Human Cognitive and Behavioral Science — Request for applications, (9) 2021 Pilot Award — Request for applications, (10) SFARI Supplement to Enhance Equity and Diversity (SEED) — Request for applications, (11) Upcoming lecture: Jake Gratten and Naomi Wray, “New research results from the Australian Autism Biobank Study, (12) Upcoming lecture: Federico Bolognani, Stuart Cobb, Yael Weiss, and Randal Carpenter, “Small molecules, genes and antisense oligonucleotides: Industry perspectives on treatment development for ASD, (13) Upcoming lecture: David Ledbetter, Joseph Buxbaum, and Heather Mefford, “What do we mean by ‘autism risk genes’?”, (14) Past lecture: Elizabeth Berry-Kravis, “Clinical trials and cyclic AMP in fragile X syndrome: A life journey”.

This issue of the SFARI newsletter includes: (1) SFARI Summer 2020 Pilot awardees, (2) SPARK update: New phenotypic data now available, (3) Simons Searchlight: Research matching program launched, (4) SFARI Gene: January 2021 data release, (5) SfN Global Connectome: Presentations by SFARI Investigators, (6) SFARI Bridge to Independence fellows discuss new research findings and career challenges at virtual retreat, (7) SFARI blog: Alice Luo Clayton, “SFARI Bridge to Independence Award program: Looking back, looking forward”, (8) Highlights of SFARI-funded research, (9) 2021 Bridge to Independence Award— Request for applications, (10) Maternal COVID-19 as a Potential Risk for Autism: Supplemental Funding for Ongoing Pregnancy cohorts – Request for applications, (11) SPARK Research Match Diversity, Equity and Inclusivity – Request for applications, (12) SFARI Supplement to Enhance Equity and Diversity (SEED) — Request for applications, (13) Upcoming lecture: Elizabeth Berry-Kravis, “Clinical trials and cyclic AMP in fragile X syndrome: A life journey.”

This issue of the SFARI newsletter includes: (1) New collaboration between SFARI and Nancy Lurie Marks Family Foundation will generate iPS cells for autism research, (2) Transition in SFARI directorship: Update, (3) Simons Searchlight new data release, (4) SFARI Gene: October 2020 data release, (5) New Autism BrainNet website has launched, (6) ASHG 2020 Virtual Meeting: Presentations by SFARI Investigators and collaborators, (7) Workshop report: SFARI workshop discusses opportunities to study maternal infection and autism risk during COVID-19 pandemic, (8) SFARI Conversation with Kevin Eggan, (9) Highlights of SFARI-funded research, (10) SFARI Supplement to Enhance Equity and Diversity (SEED) — Request for applications, (11) 2021 Bridge to Independence Award — Request for applications, (12) Past lecture: Evan Eichler, “Rare variants and the genetics of autism.”

This issue of the SFARI newsletter includes: (1) SFARI 2020 Bridge to Independence fellows announced, (2) New rat models available to study autism spectrum disorder, (3) On rat models: A SFARI Conversation with Investigators Peter Kind and Loren Frank, (4) SFARI Gene: New data release, (5) Reminder about SFARI’s acknowledgment policy, (6) SFARI Spring 2020 science meeting goes online, (7) Highlights of SFARI-funded research, (8) SFARI Supplement to Enhance Equity and Diversity (SEED) — Request for applications, (9) Past lecture: Emmanuel Mignot, “Phenotyping Sleep”.

This issue of the SFARI newsletter includes: (1) SFARI 2020 Research awardees, (2) SFARI’s response to appeals for racial justice in science and society, (3) SPARK update: New phenotypic data now available, (4) SFARI Gene: New data release, (5) Requesting SFARI data and biospecimens during COVID-19 pandemic, (6) SFARI abstracts and e-posters at INSAR 2020 Virtual, (7) SFARI Investigator and board member elected to the National Academy of Sciences, (8) SFARI Investigators and board member elected to the American Academy of Arts & Sciences, (9) Workshop report: SFARI workshop explores challenges and opportunities of gene therapies for autism spectrum disorder, (10) Highlights of SFARI-funded research, (11) Past webinar: Allyson Berent, “From parent advocate to nonprofit chief science officer, to biotherapeutic company cofounder — A personal journey through drug development for Angelman syndrome.”